Gene · 3122
NIH grants3,569
NIH projects whose papers are about the gene, through NIH's grant-paper links.
61 to 80 of 3,569
Download this page as JSON| Project | Title | Its papers about the gene | Newest fiscal year |
|---|---|---|---|
| R01HL142068 | T Cell Immunity in Giant Cell Arteritis | 3 | 2025 |
| R01HL145372 | Spatiotemporal genomic regulation of disease initiation and progression in pulmonary fibrosis | 3 | 2025 |
| R01NS064934 | Mechanisms of LRRK2 Mediated Neurotoxicity | 3 | 2025 |
| T32GM144273 | Medical Scientist Training Program | 3 | 2025 |
| T32HL007605 | Research training in respiratory biology | 3 | 2025 |
| U10CA180888 | SWOG Network Group Operations Center of the NCTN | 3 | 2025 |
| U19AI057266 | Vaccine and Infection Induced Immunity in the Young and Aged | 3 | 2025 |
| U24AG041689 | THE NIA GENETICS OF ALZHEIMER'S DISEASE DATA STORAGE SITE | 3 | 2025 |
| UC7AI094660 | Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 Clinical Trial Not Allowed) | 3 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 3 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 3 | 2025 |
| UL1TR002345 | Washington University Institute of Clinical and Translational Sciences | 3 | 2025 |
| ZICBC010948 | DNA Sequencing and FACS Core Facilities | 3 | 2025 |
| I01BX002301 | Combining Immune Therapy with Targeted Therapies to Improve Melanoma Survival | 2 | 2025 |
| I01CX001702 | Genetic Movement Disorders: Etiologies and Pathogeneses | 2 | 2025 |
| IK2BX005875 | The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance | 2 | 2025 |
| IK6BX004209 | BLRD Research Career Scientist Award Application | 2 | 2025 |
| K08AR078251 | Mechanisms of sex discrepancy in autoimmune disease: Regulation of the female-biased VGLL3 immune pathway | 2 | 2025 |
| K12CA167540 | Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology | 2 | 2025 |
| P01AI042288 | Immune Function and the Progression to Type 1 Diabetes | 2 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.1.0
Sources 11
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNone stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GeneNone named. Public domain as US government information
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3122/grants?page=4